These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32862795)

  • 1. Risk Factors for Cannabis-Related Mental Health Harms in Older Adults: A Review.
    Hudson A; Hudson P
    Clin Gerontol; 2021; 44(1):3-15. PubMed ID: 32862795
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of medical and non-medical cannabis use in older adults: protocol for a scoping review.
    Wolfe D; Corace K; Rice D; Smith A; Kanji S; Conn D; Willows M; Garber GE; Puxty J; Moghadam E; Skidmore B; Garritty C; Thavorn K; Moher D; Hutton B
    BMJ Open; 2020 Feb; 10(2):e034301. PubMed ID: 32114474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations.
    Fischer B; Jeffries V; Hall W; Room R; Goldner E; Rehm J
    Can J Public Health; 2011; 102(5):324-7. PubMed ID: 22032094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impacts of medical and non-medical cannabis on the health of older adults: Findings from a scoping review of the literature.
    Wolfe D; Corace K; Butler C; Rice D; Skidmore B; Patel Y; Thayaparan P; Michaud A; Hamel C; Smith A; Garber G; Porath A; Conn D; Willows M; Abramovici H; Thavorn K; Kanji S; Hutton B
    PLoS One; 2023; 18(2):e0281826. PubMed ID: 36800328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use, attitudes, and legal status in the U.S.: A review.
    Carliner H; Brown QL; Sarvet AL; Hasin DS
    Prev Med; 2017 Nov; 104():13-23. PubMed ID: 28705601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms.
    Campeny E; López-Pelayo H; Nutt D; Blithikioti C; Oliveras C; Nuño L; Maldonado R; Florez G; Arias F; Fernández-Artamendi S; Villalbí JR; Sellarès J; Ballbè M; Rehm J; Balcells-Olivero MM; Gual A
    Eur Neuropsychopharmacol; 2020 Apr; 33():1-35. PubMed ID: 32165103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study.
    Blanco C; Hasin DS; Wall MM; Flórez-Salamanca L; Hoertel N; Wang S; Kerridge BT; Olfson M
    JAMA Psychiatry; 2016 Apr; 73(4):388-95. PubMed ID: 26886046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use patterns and motives: A comparison of younger, middle-aged, and older medical cannabis dispensary patients.
    Haug NA; Padula CB; Sottile JE; Vandrey R; Heinz AJ; Bonn-Miller MO
    Addict Behav; 2017 Sep; 72():14-20. PubMed ID: 28340421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report.
    Cooper K; Chatters R; Kaltenthaler E; Wong R
    Health Technol Assess; 2015 Jul; 19(56):1-130. PubMed ID: 26202542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.
    Fischer B; Russell C; Sabioni P; van den Brink W; Le Foll B; Hall W; Rehm J; Room R
    Am J Public Health; 2017 Aug; 107(8):e1-e12. PubMed ID: 28644037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cannabis in response to the opioid crisis: A review of the literature.
    Vyas MB; LeBaron VT; Gilson AM
    Nurs Outlook; 2018; 66(1):56-65. PubMed ID: 28993073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the public health impacts of legalizing recreational cannabis use in the United States.
    Hall W; Lynskey M
    Addiction; 2016 Oct; 111(10):1764-73. PubMed ID: 27082374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing heterogeneity among people who use cannabis for medicinal reasons: A latent class analysis of a nationally representative Canadian sample.
    Coelho SG; Wardell JD
    Int J Drug Policy; 2023 Jul; 117():104076. PubMed ID: 37247474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS-16).
    Lintzeris N; Driels J; Elias N; Arnold JC; McGregor IS; Allsop DJ
    Med J Aust; 2018 Aug; 209(5):211-216. PubMed ID: 30092752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis potency and contamination: a review of the literature.
    McLaren J; Swift W; Dillon P; Allsop S
    Addiction; 2008 Jul; 103(7):1100-9. PubMed ID: 18494838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study.
    van der Pol P; Liebregts N; de Graaf R; Korf DJ; van den Brink W; van Laar M
    Drug Alcohol Depend; 2013 Dec; 133(2):352-9. PubMed ID: 23886472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis health knowledge and risk perceptions among Canadian youth and young adults.
    Leos-Toro C; Fong GT; Meyer SB; Hammond D
    Harm Reduct J; 2020 Aug; 17(1):54. PubMed ID: 32746859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cannabis use among people with psychotic or depressive disorders: a systematic review.
    Baker AL; Hides L; Lubman DI
    J Clin Psychiatry; 2010 Mar; 71(3):247-54. PubMed ID: 20331929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical cannabis and mental health: A guided systematic review.
    Walsh Z; Gonzalez R; Crosby K; S Thiessen M; Carroll C; Bonn-Miller MO
    Clin Psychol Rev; 2017 Feb; 51():15-29. PubMed ID: 27816801
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.